FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W116122327> ?p ?o ?g. }

• W116122327 endingPage "161" @default.
• W116122327 startingPage "158" @default.
• W116122327 abstract "To begin, it should be clarified that the term “artificial blood” is really a misnomer. The complexity of blood is far too great to allow for absolute duplication in a laboratory. Instead, researchers have focused their efforts on creating artificial substitutes for 2 important functions of blood: oxygen transport by red blood cells and hemostasis by platelets.A number of driving forces have led to the development of artificial blood substitutes (1). One major force is the military, which requires a large volume of blood products that can be easily stored and readily shipped to the site of casualties. Another force is HIV; with the advent of this virus, the medical community and the public suddenly became aware of the significance of transfusion-transmitted diseases and became concerned about the safety of the national blood supply. A third force is the growing shortage of blood donors. Approximately 60% of the population is eligible to donate blood, but fewer than 5% are regular blood donors (2). A unit of blood is transfused every 3 seconds in the USA, and the number of units transfused each year has been increasing at twice the rate of donor collection.Artificial blood products offer many important benefits (3). First, they are readily available and have a long shelf life, allowing them to be stocked in emergency rooms and ambulances and easily shipped to areas of need. Second, they can undergo filtration and pasteurization processes to virtually eliminate microbial contamination. No product can claim to be 100% risk-free for infectious agents, but these substitutes have a greatly increased level of safety. Third, they do not require blood typing, so they can be infused immediately and for all patient blood types. Fourth, they do not appear to cause immunosuppression in the recipient.In the sections that follow, the different types of red cell and platelet substitutes currently under development will be briefly reviewed." @default.
• W116122327 created "2016-06-24" @default.
• W116122327 creator A5000922755 @default.
• W116122327 date "2001-04-01" @default.
• W116122327 modified "2023-10-18" @default.
• W116122327 title "Artificial Blood: An Update on Current Red Cell and Platelet Substitutes" @default.
• W116122327 cites W1919712442 @default.
• W116122327 cites W1981225000 @default.
• W116122327 cites W2002656981 @default.
• W116122327 cites W2003034022 @default.
• W116122327 cites W2014800791 @default.
• W116122327 cites W2029382635 @default.
• W116122327 cites W2033851722 @default.
• W116122327 cites W2038348215 @default.
• W116122327 cites W2040319167 @default.
• W116122327 cites W2067681658 @default.
• W116122327 cites W2091210055 @default.
• W116122327 cites W2157270937 @default.
• W116122327 cites W2159002717 @default.
• W116122327 cites W2323490018 @default.
• W116122327 doi "https://doi.org/10.1080/08998280.2001.11927754" @default.
• W116122327 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1291332" @default.
• W116122327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16369608" @default.
• W116122327 hasPublicationYear "2001" @default.
• W116122327 type Work @default.
• W116122327 sameAs 116122327 @default.
• W116122327 citedByCount "16" @default.
• W116122327 countsByYear W1161223272012 @default.
• W116122327 countsByYear W1161223272013 @default.
• W116122327 countsByYear W1161223272014 @default.
• W116122327 countsByYear W1161223272015 @default.
• W116122327 countsByYear W1161223272016 @default.
• W116122327 countsByYear W1161223272019 @default.
• W116122327 countsByYear W1161223272021 @default.
• W116122327 crossrefType "journal-article" @default.
• W116122327 hasAuthorship W116122327A5000922755 @default.
• W116122327 hasBestOaLocation W1161223272 @default.
• W116122327 hasConcept C119599485 @default.
• W116122327 hasConcept C126322002 @default.
• W116122327 hasConcept C127413603 @default.
• W116122327 hasConcept C148043351 @default.
• W116122327 hasConcept C2776557347 @default.
• W116122327 hasConcept C2777208419 @default.
• W116122327 hasConcept C71924100 @default.
• W116122327 hasConcept C89560881 @default.
• W116122327 hasConceptScore W116122327C119599485 @default.
• W116122327 hasConceptScore W116122327C126322002 @default.
• W116122327 hasConceptScore W116122327C127413603 @default.
• W116122327 hasConceptScore W116122327C148043351 @default.
• W116122327 hasConceptScore W116122327C2776557347 @default.
• W116122327 hasConceptScore W116122327C2777208419 @default.
• W116122327 hasConceptScore W116122327C71924100 @default.
• W116122327 hasConceptScore W116122327C89560881 @default.
• W116122327 hasIssue "2" @default.
• W116122327 hasLocation W1161223271 @default.
• W116122327 hasLocation W1161223272 @default.
• W116122327 hasLocation W1161223273 @default.
• W116122327 hasLocation W1161223274 @default.
• W116122327 hasOpenAccess W116122327 @default.
• W116122327 hasPrimaryLocation W1161223271 @default.
• W116122327 hasRelatedWork W1653228448 @default.
• W116122327 hasRelatedWork W1967778889 @default.
• W116122327 hasRelatedWork W1977144149 @default.
• W116122327 hasRelatedWork W2015719133 @default.
• W116122327 hasRelatedWork W2021077492 @default.
• W116122327 hasRelatedWork W2369777381 @default.
• W116122327 hasRelatedWork W2415433815 @default.
• W116122327 hasRelatedWork W4252882498 @default.
• W116122327 hasRelatedWork W4290404170 @default.
• W116122327 hasRelatedWork W54306856 @default.
• W116122327 hasVolume "14" @default.
• W116122327 isParatext "false" @default.
• W116122327 isRetracted "false" @default.
• W116122327 magId "116122327" @default.
• W116122327 workType "article" @default.